MX2022013309A - Tratamiento y/o prevencion de una enfermedad o un sindrome relacionado con una infeccion por virus. - Google Patents

Tratamiento y/o prevencion de una enfermedad o un sindrome relacionado con una infeccion por virus.

Info

Publication number
MX2022013309A
MX2022013309A MX2022013309A MX2022013309A MX2022013309A MX 2022013309 A MX2022013309 A MX 2022013309A MX 2022013309 A MX2022013309 A MX 2022013309A MX 2022013309 A MX2022013309 A MX 2022013309A MX 2022013309 A MX2022013309 A MX 2022013309A
Authority
MX
Mexico
Prior art keywords
treatment
disease
prevention
virus infection
syndrome related
Prior art date
Application number
MX2022013309A
Other languages
English (en)
Inventor
Nikolay Zhukovsky
Original Assignee
Atlas Biotechnology S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atlas Biotechnology S A filed Critical Atlas Biotechnology S A
Priority claimed from PCT/EP2021/061597 external-priority patent/WO2021219896A1/en
Publication of MX2022013309A publication Critical patent/MX2022013309A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Abstract

La presente invención proporciona composiciones y métodos para el tratamiento y/o prevención de enfermedad o síndrome relacionado con una infección por virus. La invención se refiere además a métodos para determinar la susceptibilidad de un sujeto para este tratamiento así como un método para determinar la cantidad de la composición requerida para un tratamiento efectivo.
MX2022013309A 2020-05-01 2021-05-03 Tratamiento y/o prevencion de una enfermedad o un sindrome relacionado con una infeccion por virus. MX2022013309A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20172564 2020-05-01
EP20192016 2020-08-20
PCT/EP2021/061597 WO2021219896A1 (en) 2020-05-01 2021-05-03 Treatment and/or prevention of a disease or a syndrome related to a virus infection

Publications (1)

Publication Number Publication Date
MX2022013309A true MX2022013309A (es) 2022-11-14

Family

ID=83807521

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022013309A MX2022013309A (es) 2020-05-01 2021-05-03 Tratamiento y/o prevencion de una enfermedad o un sindrome relacionado con una infeccion por virus.

Country Status (9)

Country Link
US (1) US20230302104A1 (es)
EP (1) EP4142775A1 (es)
JP (1) JP2023523652A (es)
KR (1) KR20230005965A (es)
CN (1) CN116033917A (es)
AU (1) AU2021263106A1 (es)
CA (1) CA3174939A1 (es)
IL (1) IL297741A (es)
MX (1) MX2022013309A (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1314447C (zh) * 2004-04-12 2007-05-09 爱华生物科技(香港)有限公司 一种具有抑制蛋白酶作用的药物的制备方法
MY166314A (en) * 2011-12-30 2018-06-25 Grifols Sa Alpha1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations
CA2978917A1 (en) * 2015-03-10 2016-09-15 The Trustees Of Columbia University In The City Of New York Recombinant glut1 adeno-associated viral vector constructs and related methods for restoring glut1 expression

Also Published As

Publication number Publication date
AU2021263106A1 (en) 2022-11-03
IL297741A (en) 2022-12-01
CA3174939A1 (en) 2021-11-04
US20230302104A1 (en) 2023-09-28
EP4142775A1 (en) 2023-03-08
JP2023523652A (ja) 2023-06-06
CN116033917A (zh) 2023-04-28
KR20230005965A (ko) 2023-01-10

Similar Documents

Publication Publication Date Title
BR112018005454A2 (pt) administração de potencializadores de cftr deuterados
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
MX2019007749A (es) Composicion farmaceutica para usarse en el tratamiento o prevencion de una enfermedad relacionada con c5 y metodo para tratar o prevenir una enfermedad relacionada con c5.
MX2022000453A (es) Compuestos útiles para tratar infecciones por virus de influenza.
WO2007106404A3 (en) Vaccine for viruses that cause persistent or latent infections
MX2017012545A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
EA201891853A1 (ru) Способы лечения или предотвращения атеросклероза путем введения ингибитора angptl3
BR112021012654A2 (pt) Métodos de tratamento de infecções por tempestade de citocina, incluindo covid-19, através da inibição da interação ccr5/ccl5 (rantes) e composições para a prática da mesma
CR20210103A (es) Composición farmacéutica para usarse en el tratamiento o prevención de una enfermedad relacionada con c5 y método para tratar o prevenir una enfermedad relacionada con c5
MX2022014561A (es) Inhibidores de mek para el tratamiento o prevencion de infecciones por coronavirus y/o tormenta de citocinas por covid-19.
EA201990010A1 (ru) Вакцина против вируса инфекционного бронхита
EA202193111A1 (ru) Композиции и способы для лечения рака
BR112018000771A2 (pt) anticorpos que se ligam à sortilina e inibem a ligação de progranulina, composições farmacêuticas, preparações dos mesmos, uso de anticorpos, kit e método de prevenção ou tratamento de uma doença associada a níveis diminuídos de pgrn
ZA202207169B (en) Methods, compositions, and vaccines for treating a virus infection
EA201990988A1 (ru) Антитела против chikv и пути их применения
MX2023004869A (es) Anticuerpos contra sars-cov-2 y usos de los mismos.
EA201270192A1 (ru) Композиции и способы применения для пострадиационной защиты
BR112018072298A2 (pt) tratamento de infecções pelo vírus da zika usando inibidores da alfa-glicosidase
BR112022001025A2 (pt) Inibidores de calicreína plasmática
MX2022013309A (es) Tratamiento y/o prevencion de una enfermedad o un sindrome relacionado con una infeccion por virus.
PH12020551117A1 (en) Compositions for preventing or treating uveitis
PH12020500662A1 (en) Anti-pfrh5 antibodies and antigen-binding fragments thereof
EA202192454A1 (ru) Новый ингибитор mek для лечения вирусных и бактериальных инфекций
EA202092691A1 (ru) Соединения для устранения боли, композиции, содержащие их, и способы их применения
MX2017012539A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.